DARWIN BIOTECH
Live / Applied — Non-final action written — not yet mailed (as of 07 Oct 2026)
What this means for you
Not registered yet, but its 22 May 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79458018
- Mark type
- Stylized text
- Filed
- 22 May 2026
Goods and services
- Class 005 — Pharmaceuticals: Reagent paper for medical purposes; pharmaceutical preparations for the treatment of neurodegeneration; preparations of microorganisms for medical purposes; cultures of microorganisms for medical or veterinary use; pharmaceutical preparations for the treatment of Amyotrophic lateral sclerosis; pharmaceutical preparations for the central nervous system; pharmaceutical preparations for wounds; medicines for the treatment of cardiovascular and cerebrovascular diseases; biological tissue cultures for medical purposes; stem cells for medical purposes.
- Class 010 — Medical apparatus: Medical apparatus and instruments for treating cardiovascular disease; manually-operated exercise equipment for physical therapy purposes; massage apparatus [for medical purposes]; apparatus for the regeneration of stem cells for medical purposes; nerve stimulator apparatus; surgical implants comprising artificial material.
- Class 035 — Advertising and business services: Advertising services; organization of exhibitions for commercial or advertising purposes; updating of advertising material; online advertising on a computer network; production of advertising films; sales promotion for others; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; demonstration of goods; business management consultancy; negotiation and conclusion of commercial transactions for third parties.
- Class 042 — Scientific and technological services: Cell free protein synthesis technology research; biochemical research and analysis; development of pharmaceutical preparations and medicines; research and development of new products; product safety testing services; scientific investigation for medical purposes; chemical research and analysis; DNA screening for scientific research purposes; research of induced pluripotent stem cells; stem cell research services.
Owner
Prosecution history
- 08 Oct 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 07 Oct 2026 — NON-FINAL ACTION WRITTEN
- 06 Oct 2026 — ASSIGNED TO EXAMINER
- 05 Oct 2026 — APPLICATION FILING RECEIPT MAILED
- 05 Oct 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 05 Oct 2026 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 10 Sept 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB